Bumedinst 6224.8B Tuberculosis Control Program (Enclosures 1 And 2)

Front 1

Screening After Receipt of PCS Orders to a Comissioned Vessel

Back 1

All personnel will be screened for LTBI during the Operational Suitability Screening. If positive and using NAVMED 6224/8 for screening should proceed to testing. Screenings and testings should be completed 6 months prior to reporting to a comissioned vessel to be acceptable.

Front 2

LTBI Testing Guidance
-Tuberculin, Purified Protein Derivative (PPD)-

Back 2

The approved tuberculin skin test material for routine Mantoux test is Tween-80-Stabilized Intermediate Strength PPD. Preferred product is Tubersol from Sanofi Pasteur from Parkedale Pharmaceuticals. If Tubersol unavailable use Aplisol.

Front 3

LTBI Testing Guidance
-Recording Administration-

Back 3

Record Information on...
1. NAVMED 6230/4
2. Adult Immunization Record
3. NAVMED 6230/5
4. Child Immunization Record
Record Electronically in...
1. Armed Forces Health Longitudinal Technology Application (AHLTA)
2. Medical Readiness Reporting System (MRRS)
3. Shipboard Non-Tactical ADP Program (SNAP)
4. Automated Medical System (SAMS)
Include Information...
1. Date Administered
2. Type
3. Strength
4. Manufacturer
5. Lot Number
6. Route

Front 4

LTBI Testing Guidance
-Measurement-

Back 4

PPD must be read in 48 to 72 hours after administration for reaction. Measure TST induration to nearest whole millimeter. If patient returns after 72 hours record as "Not Read" and administer in opposite arm.

Front 5

LTBI Testing Guidance
-Recording Result-

Back 5

Enter TST induration result on NAVMED 6230/4 or 6230/5 then electronically AHLTA, MRRS, or SAMS. If no induration record result as "0 mm" or "zero mm".

Front 6

Special Situations
-Pregnancy-

Back 6

TST's are both safe and reliable throughout pregnancy.

Front 7

Special Situations
-Positive TST-

Back 7

Those who are deploying with a positive TST under evaluation should not deploy until completion of evaluation.